ECOG Protocols Active as of 08/20/08

Click on the protocol number to view the NCI's PDQ description of the protocol.

HEAD AND NECK COMMITTEE


ProtocolTitle
E1302 Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa, Gefitinib) In Performance Status 2 Or Previously Treated Patients With Recurrent Or Metastatic Head And Neck Cancer
Activation Date: 06-aug-2004
E1304 Phase II Two Arm Trial of the Proteasome Inhibitor, PS-341 (VELCADETM) in Combination with Irinotecan or PS-341 Alone Followed by the Addition of Irinotecan at Time of Progression in Patients with Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Activation Date: 20-jul-2005
ECOG Participants(requires Adobe Acrobat)
E1305 A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer
Activation Date: 08-aug-2008

Back

How to contact ECOG

All contents copyright © 1998 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: 08/20/08